Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2010 | 04-2009 | 04-2007 | |
| Sales | 260 | 650 | 0 |
| Cost of Goods | 220 | 0 | N/A |
| Gross Profit | 30 | 650 | N/A |
| Operating Expenses | 2,360 | 0 | 0 |
| Operating Income | -2,100 | 650 | N/A |
| Interest Expense | 290 | 0 | 0 |
| Other Income | -3,600 | 0 | 0 |
| Pre-tax Income | -5,990 | 650 | 0 |
| Net Income Continuous | -5,937 | -6,042 | N/A |
| Net Income | $-5,990 | $-6,040 | $N/A |
| EPS Basic Total Ops | -28.57 | -42.86 | N/A |
| EPS Basic Continuous Ops | -24.14 | -42.82 | N/A |
| EPS Diluted Total Ops | -28.57 | -42.86 | N/A |
| EPS Diluted Continuous Ops | -24.14 | -37.86 | N/A |
| EBITDA(a) | $-1,990 | $650 | $N/A |